Maitake MD-Fraction Mushroom Extract Therapy
To assist in the treatment of cancer, HIV, Hepatitis and Immune System Ddiseases.
Maitake: King of Mushrooms
Maitake (scientific name grifola frondosa) is indigenous to the northeastern part of Japan. In Japan, maitake can grow to more than 20 kilogram in size, earning it the title of King of Mushrooms. Maitake is so named not only for its large size but also for its amazing health benefits. Apart from the health benefits, it is also highly sought after for its excellent taste.
Medicinal mushroom-derived beta-glucans are notable for their ability to modulate the immune system. Sources of beta-glucan include various species of mushrooms, such as reishi, shiitake and maitake. Beta-glucans are known as “biological response modifiers” because of their ability to activate the immune system. Immunologists have discovered that receptors on the surface of innate immune cells called dectin-1 and complement receptor 3 (CR3 or CD11b/CD18) are responsible for binding to beta-glucans, allowing the immune cells to recognize them.
Maitake MD-Fraction – the original from Japan
Maitake beta-glucan MD-Fraction is the original patented product made to ISO standards in Japan.
A phase I/II human trial, conducted by the Memorial Sloan–Kettering Cancer Center, showed maitake can stimulate the immune system of breast cancer patients. Small experiments with human cancer patients have shown that maitake can stimulate the immune system cells like NK cells. In vitro research has also shown that maitake can stimulate immune system cells, confirming the clinical experiments in humans.
Lesser studies with human cancer patients have revealed that the maitake D-fraction portion of the maitake mushroom is effective against cancer. In vitro research demonstrated that maitake has potential anti-metastatic properties. In 1997, the US Food and Drug Administration (FDA) approved an Investigational New Drug Application for a part of the mushroom.
Research has shown maitake has a hypoglycemic effect and may be beneficial in the management of diabetes. The reason maitake lowers blood sugar is due to the fact the mushroom contains a natural alpha glucosidase inhibitor. Alpha-glucosidase inhibitors are saccharides that act as competitive inhibitors of enzymes needed to digest carbohydrates. Since cancer cells have a preference for glucose, lowering blood sugar levels in cancer patients tends to produce beneficial effects for the patient. Clinical studies in cancer patients with Metformin, a common anti-diabetic drug, showed similar beneficial effects.
Maitake contains antioxidants and may partially inhibit the enzyme cyclooxygenase. An experiment showed that an extract of maitake inhibited angiogenesis via inhibition of the vascular endothelial growth factor (VEGF).
- The High-Dose Maitake MD-Fraction is 400 mg (2 capsules taken twice daily) about 30 minutes before breakfast and dinner.
- The Moderate-Dose Maitake MD-Fraction is 200 mg (1 capsule taken twice daily) about 30 minutes before breakfast and dinner.
- Side effects are not common but for people experiencing a mild stomach disorder, it is recommended to start with a lower dose or take it with a small amount of food, or at the beginning or end of a meal.